Puma Biotechnology
PBYI
PBYI
77 hedge funds and large institutions have $86M invested in Puma Biotechnology in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 89 → 77 (-12)
25% less capital invested
Capital invested by funds: $115M → $86M (-$29.3M)
55% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 22
Holders
77
Holding in Top 10
1
Calls
$1.13M
Puts
$229K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$955K | |
| 3 | +$681K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$627K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$564K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1.27M | |
| 3 | -$1.15M | |
| 4 |
D.E. Shaw & Co
New York
|
-$559K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$492K |